Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
05/2003
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313699A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1146865B1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003CA2412466A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2002095393A3 Drug evolution: drug design at hot spots
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096991 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at SO2Cl group reducing at the nitro group; reacting with carbamate
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096856 Compounds such as N-((dimethylamino)acetyl)-1-methyl-N-(3, 4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide for therapy of cancer
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/21/2003EP1312603A1 Polymerisable bis-sulphonyl derivatives and their use for preparing ion exchange membranes
05/21/2003EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311474A1 Sulfonamide derivatives
05/21/2003EP1311192A1 $g(in vivo) imaging
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003CN1419534A Diphenyl ether compounds useful in therapie
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566034 Photographic material containing a novel hydrazine type
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2002085303A3 Substituted tetracycline compounds for the treatment of malaria
05/15/2003US20030092947 Process for preparing biphenyl compounds
05/15/2003US20030092940 Heating one or more aromatic compounds in presence of a first reactant so as to form one or more product compounds containing aromatic-sulfonimide or aromatic-methylidynetrissulfonyl bonds
05/15/2003US20030092748 Benzenesulfonamide derivatives and their use as MEK inhibitors
05/15/2003US20030092715 Aryl and biaryl compounds having MCH modulatory activity
05/15/2003US20030092634 Novel compounds and compositions as protease inhibitors
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/14/2003EP1309573A1 Urethane derivatives
05/14/2003EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia
05/14/2003CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors
05/14/2003CN1418209A Carbocyclic side chain containing metalloprotease inhibitors
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1417206A Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003CA2361906A1 Water-soluble fluorinated sulfonamides as topical carbonic anhydrase inhibitors, for treating glaucoma
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037865A1 Novel anticancer compounds
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037851A1 Racemic tamsulosin free base and methods of making the same
05/08/2003WO2003037850A1 Process for resolution of tamsulosin
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2002076928A3 Alkylamine derivatives as antifouling agents
05/08/2003WO2002048097A9 Compounds, compositions and methods for treatment of parasitic infections
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088103 PPARgamma modulators
05/08/2003US20030087945 Sulfonylaminocarboxylic acids
05/08/2003US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087151 Low melting point
05/08/2003CA2468761A1 Novel anticancer compounds
05/08/2003CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/07/2003EP1308436A1 Calcium receptor antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
05/06/2003US6559261 A method for producing a polymeric material, said method comprising subjecting a starting material which includes two multiple bonds which are activated so that they will take part in a polymerisation reaction and wherein the multiple bonds
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient
05/06/2003CA2056068C Process
05/02/2003EP1305281A1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof
05/01/2003WO2003035611A1 Aromatic imide and aromatic methylidynetrissulfonyl compounds and method of making
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035608A1 A method of the preparation of (r)-(-)-5`2-`2-(2-ethoxyphenoxy) ethylamino! propyl!-2-methoxybenzenesulphonamide (tamsulosin)
05/01/2003WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
05/01/2003WO2002026701A3 Ionic liquids and their use as solvents
05/01/2003US20030083517 Methods of preparing sulfinamides and sulfoxides
05/01/2003US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
05/01/2003CA2463322A1 Aromatic imide and aromatic methylidynetrissulfonyl compounds and method of making
05/01/2003CA2463290A1 Zwitterionic imides
04/2003
04/30/2003CN1414955A Nitro-sulfobenzamides compound
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 177